Free Trial

Procter & Gamble (PG) Stock Forecast & Price Target

Procter & Gamble logo
$171.19 +4.80 (+2.88%)
As of 02:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Procter & Gamble - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
6
Buy
16

Based on 22 Wall Street analysts who have issued ratings for Procter & Gamble in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 6 have given a hold rating, 13 have given a buy rating, and 3 have given a strong buy rating for PG.

Consensus Price Target

$181.50
6.03% Upside
According to the 22 analysts' twelve-month price targets for Procter & Gamble, the average price target is $181.50. The highest price target for PG is $209.00, while the lowest price target for PG is $164.00. The average price target represents a forecasted upside of 6.03% from the current price of $171.19.
Get the Latest News and Ratings for PG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Procter & Gamble and its competitors.

Sign Up

PG Analyst Ratings Over Time

TypeCurrent Forecast
4/17/24 to 4/17/25
1 Month Ago
3/18/24 to 3/18/25
3 Months Ago
1/18/24 to 1/17/25
1 Year Ago
4/18/23 to 4/17/24
Strong Buy
3 Strong Buy rating(s)
3 Strong Buy rating(s)
2 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
12 Buy rating(s)
14 Buy rating(s)
12 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$181.50$181.47$179.65$168.53
Forecasted Upside6.03% Upside8.24% Upside11.34% Upside7.37% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Remove Ads

PG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Procter & Gamble Stock vs. The Competition

TypeProcter & GambleConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.86
2.55
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside7.16% Upside67.75% Upside26.77% Upside
News Sentiment Rating
Positive News

See Recent PG News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/11/2025JPMorgan Chase & Co.
3 of 5 stars
Andrea Teixeira
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$181.00 ➝ $172.00+3.20%
4/3/2025Truist Financial
2 of 5 stars
Bill Chappell
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$180.00 ➝ $185.00+8.99%
3/27/2025Barclays
3 of 5 stars
L. Lieberman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight
3/17/2025Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Lingnau
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
2/24/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Korinne Wolfmeyer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$173.00 ➝ $172.00+1.08%
2/10/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy
1/23/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Nik Modi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$164.00 ➝ $164.00-0.81%
1/23/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Astrachan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetHold ➝ Hold$161.00 ➝ $165.00+0.60%
1/23/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Chris Carey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$176.00 ➝ $180.00+9.38%
1/23/2025DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Weiser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$209.00 ➝ $209.00+27.00%
10/21/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$174.00 ➝ $191.00+12.88%
10/21/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$180.00 ➝ $183.00+8.25%
10/4/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Zamacona
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$190.00+12.36%
8/23/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Badishkanian
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/1/2024Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Widjaja
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$182.00 ➝ $175.00+5.03%
7/23/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$189.00+12.31%
7/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$171.00 ➝ $176.00+4.13%
7/10/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$177.00 ➝ $190.00+13.96%
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$187.00+11.14%
4/25/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$180.00 ➝ $185.00+13.49%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$168.00+5.70%
1/24/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$170.00 ➝ $175.00+13.65%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$162.00 ➝ $153.00+7.02%
9/22/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$179.00+17.64%
9/8/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Andersen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
8/1/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$170.00 ➝ $175.00+11.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:00 PM ET.


Should I Buy Procter & Gamble Stock? PG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, April 15, 2025. Please send any questions or comments about these Procter & Gamble pros and cons to contact@marketbeat.com.

Procter & Gamble
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Procter & Gamble:

  • Procter & Gamble's stock is currently priced at $166.96, reflecting a 2.1% increase recently, indicating positive market sentiment and potential for further growth.
  • The company reported a strong quarterly earnings result with earnings per share of $1.88, surpassing analysts' expectations, which demonstrates robust financial performance and effective management.
  • Procter & Gamble has a solid net margin of 18.35%, suggesting that it retains a significant portion of revenue as profit, which is attractive for investors seeking stable returns.
  • The firm has a return on equity of 33.00%, indicating efficient use of shareholders' equity to generate profits, which is a positive sign for potential investors.
  • With 65.77% of its stock owned by institutional investors and hedge funds, there is a level of confidence from large investors, which can be reassuring for individual investors.

Procter & Gamble
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Procter & Gamble for these reasons:

  • The company's current ratio is 0.76, which is below the ideal benchmark of 1, indicating potential liquidity issues that could affect its ability to meet short-term obligations.
  • Procter & Gamble has a price-to-earnings (P/E) ratio of 26.59, which may suggest that the stock is overvalued compared to its earnings, potentially limiting future price appreciation.
  • The price-to-earnings-growth (PEG) ratio of 3.76 indicates that the stock may be expensive relative to its growth rate, which could deter value-focused investors.
  • With a beta of 0.43, the stock is less volatile than the market, which may not appeal to investors looking for high-risk, high-reward opportunities.
  • Recent increases in competition in the consumer goods sector could pressure Procter & Gamble's market share and profit margins, posing a risk to future growth.

PG Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Procter & Gamble is $181.50, with a high forecast of $209.00 and a low forecast of $164.00.

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Procter & Gamble in the last twelve months. There are currently 6 hold ratings, 13 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PG shares.

According to analysts, Procter & Gamble's stock has a predicted upside of 6.03% based on their 12-month stock forecasts.

Over the previous 90 days, Procter & Gamble's stock had 1 upgrade by analysts.

Procter & Gamble has been rated by research analysts at Barclays, DA Davidson, Erste Group Bank, JPMorgan Chase & Co., Piper Sandler, Royal Bank of Canada, Stifel Nicolaus, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Procter & Gamble more than other "consumer staples" companies. The consensus rating score for Procter & Gamble is 2.86 while the average consensus rating score for "consumer staples" companies is 2.55. Learn more on how PG compares to other companies.


This page (NYSE:PG) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners